Dataset from An Open-Label Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Versus Intravenous (IV) Administration of CINRYZE in Adolescents and Adults With Hereditary Angioedema (HAE)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00011165
下载链接
链接失效反馈官方服务：
资源简介：
The objectives of the study are to:1. Evaluate the safety and tolerability of CINRYZE administered by subcutaneous injection in subjects with hereditary angioedema2. Characterize the pharmacokinetics and pharmacodynamics of CINRYZE administered by subcutaneous injection3. Assess the immunogenicity of CINRYZE following subcutaneous administration
创建时间：
2025-06-25
